Immune checkpoint markers in gastroenteropancreatic neuroendocrine neoplasiaFlorian Bösch(Ludwig-Maximilians-Universität München), Thomas Knösel(Ludwig-Maximilians-Universität München)Endocrine Related CancerJanuary 3, 201910.1530/erc-18-0494Cited by 83SaveCiteExport RISWatch citationsRelated PapersVISTA in Soft Tissue Sarcomas: A Perspective for Immunotherapy?|Cancers|2022|6TIM-3 Qualifies as a Potential Immunotherapeutic Target in Specific Subsets of Patients with High-Risk Soft Tissue Sarcomas (HR-STS)|Cancers|2023|4